Sandy Banks: A cancer survivor, he joined a coronavirus vaccine trial. He was part of Pfizer breakthrough
LOS ANGELES — Three months ago, Dan Stepenosky, a colon cancer survivor, volunteered to help test a vaccine being developed to stop the coronavirus' spread. Last month, his teenage daughter Kearston joined him in the trial.
For the 52-year-old lifelong educator, a few weeks of aches and pains was a small price to pay to be part of the vanguard leading the way to combat COVID-19.
Today, the Calabasas father and daughter are savoring the news that the vaccine they received — developed by Pfizer and tested locally through Kaiser — has been 90% effective in protecting people from transmission of the virus in global trials. It may be in production by year's end.
"I guess we made the right bet," Stepenosky said, as the news broke. "I
You’re reading a preview, subscribe to read more.
Start your free 30 days